Literature DB >> 32404640

Usefulness of Telerehabilitation for Stroke Patients During the COVID-19 Pandemic.

Min Cheol Chang1, Mathieu Boudier-Revéret.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32404640      PMCID: PMC7268826          DOI: 10.1097/PHM.0000000000001468

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


× No keyword cloud information.
Dear Editor, Since the first case of the coronavirus disease (COVID-19) was discovered in Wuhan, Hubei Province, China, in December 2019, it has spread worldwide at an unprecedented rate. While exact mortality rates vary between countries, a range from 2% to 6% has been reported, with much higher mortality rates among the elderly (≥60 years old) and those with underlying health conditions.[1] Patients with a history of stroke are reported to be 2.5 times more likely to progress to a severe stage of COVID-19.[2] Stroke is highly prevalent among the elderly, and many patients with stroke have other underlying comorbidities such as diabetes, hypertension, and cardiovascular disease. There is thus an even higher likelihood of disease progression to the severe stage, or even death, among stroke patients with COVID-19. As COVID-19 is transmitted via person-to-person contact, stroke patients undergoing outpatient rehabilitation therapy during the COVID-19 pandemic have an increased risk of infection, as contact with other people often cannot be avoided on the way to and from the hospital. As the frequency of contact increases, the probability of becoming infected with COVID-19 also increases. The first 6 months after a stroke is a crucial period for recovery, and subacute stroke patients with disabilities regularly undergo rehabilitation therapy at a hospital, which means that these patients have a higher risk of COVID-19. Here, we suggest the utilization of telerehabilitation for stroke patients to reduce their risk of infection. Telerehabilitation refers to “providing rehabilitation service using electronic communication technologies”[3]. As such, rehabilitation therapy could be implemented remotely without the physician and patient meeting in person. While there are many rehabilitation therapy methods and programs based on telerehabilitation, they typically involve the medical staff checking the patient’s condition, showing rehabilitation therapy examples to the patient or their guardian, and using photographs or videos to demonstrate how rehabilitation therapy should be performed. Motor, language, and cognitive functions can be assessed by video or by using specially designed programs. Many studies have analyzed the effectiveness of telerehabilitation, with the majority reporting that telerehabilitation is comparable to in-clinic rehabilitation in terms of improving motor, language, and cognitive functions. In 2019, Cramer et al.[3] compared the effectiveness of home-based rehabilitation for stroke patients using telemedicine (62 patients) to that of in-clinic rehabilitation (62 patients). A total of 36 therapy sessions (70 minutes each) were designed to improve arm motor function. In this study, both therapy groups displayed significant improvements in arm motor function, showing that telerehabilitation was as effective as in-clinic rehabilitation. Furthermore, over 50% of stroke patients have depression or anxiety.[4] Such psychological problems could be exacerbated during the COVID-19 pandemic, because patients are isolated from the wider community. Drug therapy and counseling must be provided to these patients. With telerehabilitation, patients can receive prescriptions for medication and counseling for psychological stabilization without visiting the hospital. The effectiveness of counseling by telemedicine has been demonstrated in many previous studies[5]. Such a service could significantly improve the mental health of stroke patients during the COVID-19 pandemic. With telerehabilitation, a physician can also determine whether a patient needs to be tested for COVID-19. If it is determined that there is no need for a COVID-19 test, then unnecessary hospital visits can be avoided. Moreover, for stroke patients with COVID-19 who are asymptomatic or have mild symptoms and are in self-quarantine at home, telerehabilitation could be used to check for changes in symptoms and quickly detect symptom exacerbation to ensure they receive on-time treatment. To summarize, we examined the beneficial effects that telerehabilitation may have on stroke patients during the COVID-19 pandemic. While rehabilitation therapy is essential for such patients, becoming infected with COVID-19 could result in severe illness and death. Protecting stroke patients from COVID-19 is therefore extremely important, and we suggest telerehabilitation as a useful approach in the rehabilitation of stroke patients during the COVID-19 pandemic.
  9 in total

1.  Effectiveness of telerehabilitation on short-term quality of life of patients after esophageal cancer surgery during COVID-19: a single-center, randomized, controlled study.

Authors:  Keqing Chen; Fei Yao; Xiaoyu Chen; Yanjuan Lin; Minqiang Kang
Journal:  J Gastrointest Oncol       Date:  2021-08

2.  Access to and Use of Internet and Social Media by Low-Morbidity Stroke Survivors Participating in a National Web-Based Secondary Stroke Prevention Trial: Cross-sectional Survey.

Authors:  Brigid Clancy; Billie Bonevski; Coralie English; Amanda L Baker; Alyna Turner; Parker Magin; Michael Pollack; Robin Callister; Ashleigh Guillaumier
Journal:  J Med Internet Res       Date:  2022-05-30       Impact factor: 7.076

3.  An Overview of Telehealth in Total Joint Arthroplasty.

Authors:  Eric N Windsor; Abhinav K Sharma; Ioannis Gkiatas; Ameer M Elbuluk; Peter K Sculco; Jonathan M Vigdorchik
Journal:  HSS J       Date:  2021-02-21

Review 4.  How COVID-19 will boost remote exercise-based treatment in Parkinson's disease: a narrative review.

Authors:  Agnes Langer; Lucia Gassner; Anna Flotz; Sebastian Hasenauer; Jakob Gruber; Laurenz Wizany; Rochus Pokan; Walter Maetzler; Heidemarie Zach
Journal:  NPJ Parkinsons Dis       Date:  2021-03-08

Review 5.  COVID-19 and cerebrovascular diseases: a comprehensive overview.

Authors:  Georgios Tsivgoulis; Lina Palaiodimou; Ramin Zand; Vasileios Arsenios Lioutas; Christos Krogias; Aristeidis H Katsanos; Ashkan Shoamanesh; Vijay K Sharma; Shima Shahjouei; Claudio Baracchini; Charalambos Vlachopoulos; Rossetos Gournellis; Petros P Sfikakis; Else Charlotte Sandset; Andrei V Alexandrov; Sotirios Tsiodras
Journal:  Ther Adv Neurol Disord       Date:  2020-12-08       Impact factor: 6.570

6.  Does COVID-19 Impact Less on Post-stroke Aphasia? This Is Not the Case.

Authors:  Francesca Pisano; Alberto Giachero; Cristian Rugiero; Melanie Calati; Paola Marangolo
Journal:  Front Psychol       Date:  2020-11-30

7.  The Effective Cognitive Assessment and Training Methods for COVID-19 Patients With Cognitive Impairment.

Authors:  Dong Wen; Jian Xu; Zhonglin Wu; Yijun Liu; Yanhong Zhou; Jingjing Li; Shaochang Wang; Xianlin Dong; M Iqbal Saripan; Haiqing Song
Journal:  Front Aging Neurosci       Date:  2022-01-11       Impact factor: 5.750

8.  Consensus Statement on Neurorehabilitation during COVID-19 Times: Expert Group on Behalf of the Indian Federation of Neurorehabilitation (IFNR).

Authors:  Rajinder K Dhamija; Abhishek Srivastava; Sonal Chauhan; Urvashi Shah; Taral Nagda; Deepak Palande; Sonal Chitnis; P S Dantala; John M Solomon; S Murali Krishnan; Hitav Someshwar; Nirmal Surya
Journal:  Ann Indian Acad Neurol       Date:  2021-03-22       Impact factor: 1.383

Review 9.  Rehabilitation Care at the Time of Coronavirus Disease-19 (COVID-19) Pandemic: A Scoping Review of Health System Recommendations.

Authors:  Ahmed M Negm; Adrian Salopek; Mashal Zaide; Victoria J Meng; Carlos Prada; Yaping Chang; Preeti Zanwar; Flavia H Santos; Elena Philippou; Emily R Rosario; Julie Faieta; Jason R Falvey; Amit Kumar; Timothy A Reistetter; Vanina Dal Bello-Haas; Jonathan F Bean; Mohit Bhandari; Patricia C Heyn
Journal:  Front Aging Neurosci       Date:  2022-01-04       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.